Dr Nathaniel Winer, MD | |
450 Clarkson Ave, Suite A, Brooklyn, NY 11203-2056 | |
(718) 270-6324 | |
(718) 270-2699 |
Full Name | Dr Nathaniel Winer |
---|---|
Gender | Male |
Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
Location | 450 Clarkson Ave, Brooklyn, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245225598 | NPI | - | NPPES |
02138943 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 084401-1 (New York) | Primary |
Entity Name | University Physicians Of Brooklyn, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366506271 PECOS PAC ID: 0749192284 Enrollment ID: O20040401000120 |
News Archive
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a ruling by the U.S. District Court for the District of New Jersey finding Bayer Schering's U.S. Patent No. 6,787,531 invalid. The patent is listed in the Orange Book for Bayer's oral contraception Yasmin®.
Neither type nor dosage of antiepileptic drug affects the risk of intrauterine death among pregnant women with epilepsy when given as monotherapy, suggests research.
American Medical Systems® (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the results of three major clinical studies that each point to a high degree of efficacy and patient satisfaction with AMS' minimally invasive treatment options for female stress urinary incontinence (SUI) and vaginal prolapse.
Conformetrix Ltd, a leader in optimising drug discovery and design, and AstraZeneca announced today that they have signed a research collaboration agreement under which Conformetrix's proprietary NMR-based technology will be applied across AstraZeneca's pre-clinical therapeutic pipeline to enhance lead discovery and hit identification.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Nathaniel Winer, MD 450 Clarkson Ave, Box 1205, Brooklyn, NY 11203-2056 Ph: (718) 270-6320 | Dr Nathaniel Winer, MD 450 Clarkson Ave, Suite A, Brooklyn, NY 11203-2056 Ph: (718) 270-6324 |
News Archive
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a ruling by the U.S. District Court for the District of New Jersey finding Bayer Schering's U.S. Patent No. 6,787,531 invalid. The patent is listed in the Orange Book for Bayer's oral contraception Yasmin®.
Neither type nor dosage of antiepileptic drug affects the risk of intrauterine death among pregnant women with epilepsy when given as monotherapy, suggests research.
American Medical Systems® (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the results of three major clinical studies that each point to a high degree of efficacy and patient satisfaction with AMS' minimally invasive treatment options for female stress urinary incontinence (SUI) and vaginal prolapse.
Conformetrix Ltd, a leader in optimising drug discovery and design, and AstraZeneca announced today that they have signed a research collaboration agreement under which Conformetrix's proprietary NMR-based technology will be applied across AstraZeneca's pre-clinical therapeutic pipeline to enhance lead discovery and hit identification.
› Verified 8 days ago
Dr. Alexander Usorov, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 447 Atlantic Ave, Brooklyn, NY 11217 Phone: 718-858-6300 | |
Dr. Marcellus Andre Walker, MD Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 2094 Pitkin Ave, Brooklyn, NY 11207 Phone: 718-240-0516 Fax: 718-240-0564 | |
Lotus Ahmed, D.O Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 518 Mcdonald Ave, Brooklyn, NY 11218 Phone: 917-848-5432 Fax: 347-252-6754 | |
Mrs. Sophia Schwartzman, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2700 Ocean Avenue, Brooklyn, NY 11229 Phone: 518-587-1141 | |
Dr. Haitham M Ahmed, MD, MPH Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 101 Pennsylvania Avenue, Brooklyn, NY 11207 Phone: 718-240-2000 Fax: 718-240-2260 | |
Yanjin Yang, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-3000 | |
Ashwad Afzal, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-5246 |